Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

RCUS US Equity

Arcus Biosciences, Inc.Health Care · Pharmaceutical Preparations · CIK 1724521 · FY ends Dec 31
$30.35
+0.84 (+2.85%)
USD · as of 2026-08-19 · marketstack
12 8-K filings · 2 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-0713D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by GILEAD SCIENCES, INC.sec.gov ↗
2026-08-058-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-06-128-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-058-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-208-K 8.01Other eventssec.gov ↗
2026-03-2613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-03-238-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-02-258-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-01-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2025-12-188-K 2.03Creation of a direct financial obligationsec.gov ↗
2025-12-188-K 1.01Entry into a material definitive agreementsec.gov ↗
2025-12-128-K 8.01Other eventssec.gov ↗
2025-11-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Point72 Asset Management, L.P.sec.gov ↗
2025-11-0513D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by GILEAD SCIENCES, INC.sec.gov ↗
2025-11-038-K 8.01Other eventssec.gov ↗
2025-10-288-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-148-K 8.01Other eventssec.gov ↗
2025-10-068-K 8.01Other eventssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-10-06

Every row is a filed document, checked against its EDGAR index.